Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC

ONCOLOGY

Volumn 14, Issue 7 SUPPL. 5, 2000, Pages 43-46

  Choy, Hak ^a   Chakravarthy, Anuradha ^a   Devore III, Russell F ^a   Jagasia, Madan ^a   Hande, Kenneth R ^a   Roberts, John R ^a   Johnson, David H ^a   Yunus, Furhan ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b Methodist Hospitals of Memphis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; IRINOTECAN; RADIOSENSITIZING AGENT;

CLINICAL TRIAL; DRUG SCREENING; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG EVALUATION, PRECLINICAL; HUMANS; LUNG NEOPLASMS; RADIATION-SENSITIZING AGENTS;

EID: 0034220174     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. American Cancer Society: Cancer Facts & Figures - 2000. Atlanta, Ga: American Cancer Society, 2000.
2. Dosoretz DE, Katin MJ, Blitzer PH, et al: Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 24:3-9, 1992.
3. Perez CA, Stanley K, Rubin P, et al: A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 45:2744-2753, 1980.
4. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation vs radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323:940-945, 1990.
5. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87:198-205, 1995.
6. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991.
7. Jeremic B, Shibamoto Y, Acimovic L, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study. J Clin Oncol 14:1065-1070, 1996.